第7天达成囊胚的胚胎的生育与新生儿结局:它们有临床价值吗?
该回顾性队列研究纳入2006年1月至2015年5月2908例冻融胚胎移植周期及1518例活产婴儿,采用倾向性评分匹配比较第5、6、7天玻璃化胚胎移植的生育结局与新生儿结局。第7天玻璃化胚胎移植的着床率、临床妊娠率和活产率均显著低于第5天和第6天,但新生儿低出生体重、先天畸形和早期新生儿死亡风险无统计学显著差异。
要点
- 第7天玻璃化胚胎移植的活产率为25.1%至25.6%,低于第5天和第6天。
- 第7天囊胚的新生儿低出生体重、先天畸形和早期新生儿死亡风险与第5、6天无显著差异。
- 作者建议对第6天仍未达囊胚的胚胎延长培养时间应通过随机临床试验评估。
核心结论
- 第7天达成囊胚的胚胎移植后活产率较低但仍可接受,且对子代似乎是安全的。
- 作者建议对第6天仍未达囊胚阶段的胚胎延长培养时间应通过随机临床试验评估。
研究设计与样本
- 这是一项回顾性队列研究,纳入2006年1月至2015年5月接受体外受精/卵胞浆内单精子注射冻融胚胎移植周期的2908名女性,并报告了这些周期中出生的1518名活产婴儿。
- 研究采用倾向性评分匹配,进行三组匹配比较(第5天 vs 第6天、第5天 vs 第7天、第6天 vs 第7天),比较生育结局,并比较第5、6、7天玻璃化胚胎移植所得婴儿的新生儿结局。
主要发现
- 共研究922例第5天、1752例第6天和234例第7天玻璃化胚胎移植。
- 第7天玻璃化胚胎移植的着床率、临床妊娠率和活产率均显著低于第5天(分别为23.9 vs 49.9%、31.7 vs 58.1%和25.1 vs 46.5%,均P < 0.001)。
- 第7天玻璃化胚胎移植的着床率、临床妊娠率和活产率均显著低于第6天(分别为24.7 vs 42.3%、33.0 vs 53.2%和25.6 vs 41.4%,均P < 0.001)。
- 第5天、第6天和第7天玻璃化胚胎移植组分别出生的585、869和64名婴儿中,低出生体重、先天畸形和早期新生儿死亡的发生率无统计学显著差异。
临床怎么用
- 作者认为,移植第7天达成囊胚阶段的胚胎活产率较低但仍可接受,且对子代似乎是安全的。
- 作者建议,对第6天仍未达囊胚阶段的胚胎延长培养时间应通过随机临床试验评估。
局限性
- 这是一项单中心回顾性研究,且大多数新生儿数据来自父母问卷。
- 第7天玻璃化胚胎移植周期数及这些周期出生的婴儿数仍然有限,降低了研究评估新生儿结局的效能。
- 仅对形态学较差的第3天胚胎进行延长培养,且第7天可符合玻璃化标准的囊胚质量差于第5天或第6天,两者均可能使临床妊娠率产生偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is transferring embryos that achieve blastulation on Day 7 effective and safe? SUMMARY ANSWER: Embryos that achieve blastulation on Day 7 resulted in clinically relevant rates of clinical pregnancy (32.5%) and live birth (25.2%), and newborns have a similar risk of low birth weight, congenital malformations or early neonatal death compared with those derived from Days 5 and 6 blastocysts. WHAT IS KNOWN ALREADY: Potential advantages of blastocyst transfer over cleavage embryo transfer have led to a shift toward the former in IVF practice. However, published data about the fertility outcomes of transferring embryos with a delayed blastulation on Day 7 are scarce and controversial. Moreover, there are few data available on the neonatal outcomes of Day 7 blastocysts. As a result, the clinical value of Day 7 blastocysts is uncertain. STUDY DESIGN, SIZE, DURATION: This was a retrospective cohort study that included 2908 women undergoing frozen-thawed embryo transfer cycles of IVF/ICSI from January 2006 to May 2015, and reported on the 1518 live born infants from those cycles. PARTICIPANTS/MATERIALS, SETTING, METHODS: We used propensity score matching to compare the fertility outcomes of women undergoing Day-5, Day-6 and Day-7 vitrified embryo transfers in three matched comparisons (Day 5 vs Day 6, Day 5 vs Day 7 and Day 6 vs Day 7). We also compared neonatal outcomes among babies derived from Day-5, Day-6 and Day-7 vitrified embryo transfers. MAIN RESULTS AND THE ROLE OF CHANCE: We studied 922 Day-5, 1752 Day-6 and 234 Day-7 vitrified embryo transfers. Day-7 vitrified embryo transfers had significantly lower implantation, clinical pregnancy and live birth rates than both Day-5 (23.9 vs 49.9%, 31.7 vs 58.1% and 25.1 vs 46.5%, all P < 0.001, respectively) and Day-6 (24.7 vs 42.3%, 33.0 vs 53.2% and 25.6 vs 41.4%, all P < 0.001, respectively) vitrified embryo transfers. Assessment of babies showed no statistically significant difference in the rates of low birth weight, congenital malformations and early neonatal death among the 585, 869 and 64 babies born from Day-5, Day-6 and Day-7 vitrified embryo transfer groups, respectively. LIMITATIONS, REASONS FOR CAUTION: This was a single center retrospective study, and most of the neonatal data were extracted from parental questionnaires. Besides, the number of Day-7 vitrified embryo transfer cycles and babies born from these cycles was still limited, thus reducing the power of our study in assessing neonatal outcomes. In addition, only the morphologically poorer Day 3 embryos were extendedly cultured, and poorer blastocysts were qualified for vitrification on Day 7 than on Day 5 or 6, both of which might bias clinical pregnancy rates. WIDER IMPLICATIONS OF THE FINDINGS: Transfer of embryos that reach the blastocyst stage on Day 7 results in lower but still acceptable live birth rate, and seems to be safe for the offspring. Extension of the culture time in embryos that do not reach blastocyst stage by Day 6 should be assessed in randomized clinical trials. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Nature Science Foundation of China (Grant nos. 81771533, 81571397, 81571486, 31770989 and 81501319), the Nature Science Foundation of Shanghai (Grant nos. 15ZR1424900 and 1441196300), and the Foundation of Health and Family Planning Commission of Shanghai (Grant no. 201540237). B.W.M is supported by the National Health and Medical Research Council (NHMRC) Practitioner Fellowship (GNT1082548), B.W.M reports consultancy for ObsEva, Merck and Guerbet. TRIAL REGISTRATION NUMBER: Not applicable.
引用
- Du T, Wang Y, Fan Y, et al. Fertility and neonatal outcomes of embryos achieving blastulation on Day 7: are they of clinical value? Hum Reprod. 2018. PMID: 29669005. doi:10.1093/humrep/dey092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。